CD8A and neoplasm: In this study, compared with other groups, more CD3+ and CD8+ T cells expressing IFNγ were determined in tumors of D-Nap-GFFY-T317 (TH)-treated group (Figure 4A-B, E-F), indicating more T lymphocytes and CTLs infiltrating into tumor microenvironment with activated IFNγ expression.